These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 14991337

  • 1. Botulinum toxin in tension-type headache.
    Relja M, Telarović S.
    J Neurol; 2004 Feb; 251 Suppl 1():I12-4. PubMed ID: 14991337
    [Abstract] [Full Text] [Related]

  • 2. Treatment of chronic tension-type headache with botulinum toxin A: a randomized, double-blind, placebo-controlled multicenter study.
    Schulte-Mattler WJ, Krack P, BoNTTH Study Group.
    Pain; 2004 May; 109(1-2):110-4. PubMed ID: 15082132
    [Abstract] [Full Text] [Related]

  • 3. Predictors of response to botulinum toxin type A (BoNTA) in chronic daily headache.
    Mathew NT, Kailasam J, Meadors L.
    Headache; 2008 Feb; 48(2):194-200. PubMed ID: 17868356
    [Abstract] [Full Text] [Related]

  • 4. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
    Cady R, Schreiber C.
    Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
    [Abstract] [Full Text] [Related]

  • 5. Botulinum toxin a in the treatment of chronic tension-type headache with cervical myofascial trigger points: a randomized, double-blind, placebo-controlled pilot study.
    Harden RN, Cottrill J, Gagnon CM, Smitherman TA, Weinland SR, Tann B, Joseph P, Lee TS, Houle TT.
    Headache; 2009 May; 49(5):732-43. PubMed ID: 19178577
    [Abstract] [Full Text] [Related]

  • 6. Treatment of chronic tension-type headache with botulinum toxin: a double-blind, placebo-controlled clinical trial.
    Padberg M, de Bruijn SF, de Haan RJ, Tavy DL.
    Cephalalgia; 2004 Aug; 24(8):675-80. PubMed ID: 15265057
    [Abstract] [Full Text] [Related]

  • 7. Treatment of tension-type headache with botox: a review of the literature.
    Rozen D, Sharma J.
    Mt Sinai J Med; 2006 Jan; 73(1):493-8. PubMed ID: 16470328
    [Abstract] [Full Text] [Related]

  • 8. Botulinum toxin type a for the prophylaxis of chronic daily headache: subgroup analysis of patients not receiving other prophylactic medications: a randomized double-blind, placebo-controlled study.
    Dodick DW, Mauskop A, Elkind AH, DeGryse R, Brin MF, Silberstein SD, BOTOX CDH Study Group.
    Headache; 2005 Apr; 45(4):315-24. PubMed ID: 15836567
    [Abstract] [Full Text] [Related]

  • 9. Botulinum toxin A injection into corrugator muscle for frontally localised chronic daily headache or chronic tension-type headache.
    de Ru JA, Buwalda J.
    J Laryngol Otol; 2009 Apr; 123(4):412-7. PubMed ID: 18588738
    [Abstract] [Full Text] [Related]

  • 10. Treatment of tension-type headache with botulinum toxin: a pilot study.
    Schulte-Mattler WJ, Wieser T, Zierz S.
    Eur J Med Res; 1999 May 26; 4(5):183-6. PubMed ID: 10336407
    [Abstract] [Full Text] [Related]

  • 11. Duration of migraine is a predictor for response to botulinum toxin type A.
    Eross EJ, Gladstone JP, Lewis S, Rogers R, Dodick DW.
    Headache; 2005 Apr 26; 45(4):308-14. PubMed ID: 15836566
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of botulinum toxin type A for the prophylaxis of episodic migraine headaches: a meta-analysis of randomized, double-blind, placebo-controlled trials.
    Shuhendler AJ, Lee S, Siu M, Ondovcik S, Lam K, Alabdullatif A, Zhang X, Machado M, Einarson TR.
    Pharmacotherapy; 2009 Jul 26; 29(7):784-91. PubMed ID: 19558252
    [Abstract] [Full Text] [Related]

  • 13. [Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis].
    Wissel J, Entner T.
    Wien Klin Wochenschr; 2001 Jul 26; 113 Suppl 4():20-4. PubMed ID: 15506048
    [Abstract] [Full Text] [Related]

  • 14. Botulinum Toxin Type A in the treatment of chronic migraine without medication overuse.
    Freitag FG, Diamond S, Diamond M, Urban G.
    Headache; 2008 Feb 26; 48(2):201-9. PubMed ID: 18042229
    [Abstract] [Full Text] [Related]

  • 15. Botulinum toxin in migraine prophylaxis.
    Göbel H.
    J Neurol; 2004 Feb 26; 251 Suppl 1():I8-11. PubMed ID: 14991336
    [Abstract] [Full Text] [Related]

  • 16. Botulinum toxin type A in the prophylactic treatment of chronic tension-type headache: a multicentre, double-blind, randomized, placebo-controlled, parallel-group study.
    Silberstein SD, Göbel H, Jensen R, Elkind AH, Degryse R, Walcott JM, Turkel C.
    Cephalalgia; 2006 Jul 26; 26(7):790-800. PubMed ID: 16776693
    [Abstract] [Full Text] [Related]

  • 17. Botulinum toxin type a prophylactic treatment of episodic migraine: a randomized, double-blind, placebo-controlled exploratory study.
    Aurora SK, Gawel M, Brandes JL, Pokta S, Vandenburgh AM, BOTOX North American Episodic Migraine Study Group.
    Headache; 2007 Apr 26; 47(4):486-99. PubMed ID: 17445098
    [Abstract] [Full Text] [Related]

  • 18. A prospective randomized controlled study of the role of botulinum toxin in whiplash-associated disorder.
    Carroll A, Barnes M, Comiskey C.
    Clin Rehabil; 2008 Jun 26; 22(6):513-9. PubMed ID: 18511531
    [Abstract] [Full Text] [Related]

  • 19. Botulinum toxin type-A (BOTOX) in the treatment of occipital neuralgia: a pilot study.
    Taylor M, Silva S, Cottrell C.
    Headache; 2008 Jun 26; 48(10):1476-81. PubMed ID: 19076646
    [Abstract] [Full Text] [Related]

  • 20. Botulinum toxin type A therapy for chronic tension-type headache: fact versus fiction.
    Gupta VK.
    Pain; 2005 Jul 26; 116(1-2):166-7; author reply 167. PubMed ID: 15927392
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.